Hedge Fund - Healthcor Management LP

Biogen Inc. (BIIB) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2022 - Q4 (2022-12-31) $0 0% 0 $282.44
2 2022 - Q3 (2022-09-30) $18,677,000 2.33% 69,950 $212.38
3 2022 - Q2 (2022-06-30) $84,358,000 8.47% 413,640 $204.43
4 2022 - Q1 (2022-03-31) $84,590,000 5.64% 401,660 $217.46
5 2021 - Q4 (2021-12-31) $108,780,000 5.91% 453,400 $257.12
6 2021 - Q3 (2021-09-30) $132,108,000 5.7% 466,830 $327.75
7 2021 - Q2 (2021-06-30) $117,489,000 4.69% 339,300 $302.94
8 2021 - Q1 (2021-03-31) $22,523,000 0.79% 80,510 $269.69
9 2020 - Q4 (2020-12-31) $2,341,000 0.09% 9,560 $259.08
10 2020 - Q2 (2020-06-30) $0 0% 0 $300.59
11 2020 - Q1 (2020-03-31) $15,187,000 0.64% 48,002 $303.47
12 2019 - Q4 (2019-12-31) $0 0% 0 $277.46
13 2019 - Q3 (2019-09-30) $83,084,000 3.14% 356,860 $232.85
14 2019 - Q1 (2019-03-31) $0 0% 0 $314.89
15 2018 - Q4 (2018-12-31) $20,095,000 0.62% 66,780 $319.14
16 2018 - Q3 (2018-09-30) $4,102,000 0.13% 11,610 $344.30
17 2016 - Q4 (2016-12-31) $0 0% 0 $296.43
18 2016 - Q3 (2016-09-30) $117,386,000 7.15% 375,000 $296.18
19 2016 - Q2 (2016-06-30) $114,865,000 6.26% 475,000 $263.54
20 2016 - Q1 (2016-03-31) $0 0% 0 $264.15
21 2015 - Q4 (2015-12-31) $14,426,000 0.87% 47,090 $287.35
22 2015 - Q3 (2015-09-30) $0 0% 0 $330.23
23 2015 - Q2 (2015-06-30) $12,983,000 0.65% 32,140 $401.33
24 2015 - Q1 (2015-03-31) $80,521,000 3.84% 190,700 $394.14
25 2014 - Q4 (2014-12-31) $0 0% 0 $323.51
26 2014 - Q3 (2014-09-30) $66,162,000 3.39% 200,000 $329.72
27 2014 - Q2 (2014-06-30) $4,414,000 0.22% 14,000 $300.97
28 2014 - Q1 (2014-03-31) $0 0% 0 $317.43
29 2013 - Q4 (2013-12-31) $7,772,000 0.47% 27,800 $258.65
30 2013 - Q3 (2013-09-30) $0 0% 0 $223.81
31 2013 - Q2 (2013-06-30) $64,560,000 3.9% 300,000 $213.68
32 2012 - Q1 (2012-03-31) $0 0% 0 $118.81
33 2011 - Q4 (2011-12-31) $5,503,000 0.2% 50,000 $109.04
34 2011 - Q3 (2011-09-30) $8,134,000 0.24% 87,326 $97.12

The displayed share prices are average quarterly stock market prices.